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Abstract
This study investigated the in vivo pulmonary toxicity of inhaled multi-walled carbon nanotubes 
(MWCNT). Mice-inhaled aerosolized MWCNT (10 mg/m3, 5 h/day) for 2, 4, 8 or 12 days. 
MWCNT lung burden was linearly related to exposure duration. MWCNT-induced pulmonary 
inflammation was assessed by determining whole lung lavage (WLL) polymorphonuclear 
leukocytes (PMN). Lung cytotoxicity was assessed by WLL fluid LDH activities. WLL fluid 
albumin concentrations were determined as a marker of alveolar air–blood barrier integrity. These 
parameters significantly increased in MWCNT-exposed mice versus controls and were dose-
dependent. Histopathologic alterations identified in the lung included (1) bronciolocentric 
inflammation, (2) bronchiolar epithelial hyperplasia and hypertrophy, (3) fibrosis, (4) vascular 
changes and (5) rare pleural penetration. MWCNT translocated to the lymph node where the deep 
paracortex was expanded after 8 or 12 days. Acute inhalation of MWCNT induced dose-
dependent pulmonary inflammation and damage with rapid development of pulmonary fibrosis, 
and also demonstrated that MWCNT can reach the pleura after inhalation exposure.
Correspondence: Dale W. Porter, PhD, Pathology and Physiology Research Branch, Health Effects Laboratory Division, National 
Institute for Occupational Safety and Health, 1095 Willowdale Road, M/S 2015, Morgantown, WV, 26505, USA. Tel: +1 304 285 
6320. Fax: +1 304 285 6389. DPorter@cdc.gov. 
Declaration of interest
This work was supported by NIOSH Nanotechnology Research Center (Project 2927ZKKV, Toxicological Effects of Aerosolized 
MWCNT). Morinobu Endo was supported by a Grant-in-Aid for Specially Promoted Research from the Ministry of Education, 
Culture, Sports, Science and Technology of Japan (MEXT) (No. 19002007). Shuji Tsuruoka and Morinobu Endo were supported by 
the Exotic Nanocarbon Project, Japan Regional Innovation Strategy Program by the Excellence, JST (Japan Science and Technology 
Agency). Takayuki Tsukada and Fuminori Munekane are employed by Hodogaya Chemical Company, the manufacturer of the 
MWCNT used in this study. The authors report no conflicts of interest. The authors alone are responsible for the content and writing 
of this paper. The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the 
National Institute for Occupational Safety and Health.
HHS Public Access
Author manuscript
Nanotoxicology. Author manuscript; available in PMC 2015 December 22.
Published in final edited form as:














characterisation; lung burden; inflammation; fibrosis; pleural penetration
Introduction
Several different multi-walled carbon nanotube (MWCNT) inhalation studies have reported 
various outcomes regarding the toxicity of MWCNT. One study reported no lung 
inflammation but did observe thickening of the alveolar septa after exposure of mice to 
MWCNT aerosol (32 mg/m3) for 8, 16 or 24 days (Li et al. 2007). A second study also 
reported that inhalation exposure of mice to MWCNT induced no significant tissue damage 
or inflammation, but alveolar macrophages (AM) contained black particles and there was 
systemic immunosuppression (Mitchell et al. 2007). Another MWCNT inhalation study 
compared the effect of MWCNT inhalation between normal and ovalbumin-sensitised mice 
(Ryman-Rasmussen et al. 2009a). In this study, mice were exposed to a MWCNT aerosol 
(100 mg/m3) for 6 h. Significant airway fibrosis was evident at 14 days post-exposure, but 
only in ovalbumin-sensitised mice, which led the authors of this study to conclude that 
inhaled MWCNT require pre-existing inflammation to cause airway fibrosis. Rats exposed 
to MWCNT aerosols up to 2.5 mg/m3 for 13 weeks showed multifocal granulomatous 
inflammation, diffuse histiocytic and neutrophilic inflammation, and intra-alveolar 
lipoproteinosis (Ma-Hock et al. 2009), while another 13-week inhalation study of rats 
exposed to MWCNT reported persistent pulmonary inflammation and granulomas in rats 
exposed to 0.4–6 mg/m3 (Pauluhn 2010).
Previous studies from our laboratory have reported extensively on the in vivo toxicity of 
MWCNT after pharyngeal aspiration exposure. Aspiration exposure of mice to MWCNT 
resulted in dose- and time-dependent pulmonary inflammation and damage at lung burdens 
approximating feasible human occupational exposures to MWCNT (Porter et al. 2010). In 
addition, MWCNT aspiration caused rapid fibrosis, persistent granulomous inflammation, 
hypertrophy and hyperplasia of bronchiolar epithelium, mucous metaplasia of the 
bronchiolar epithelium, and at the highest exposures in the 56-day post-exposure time point, 
peribronchiolar lymphatics were dilated (Porter et al. 2010). In addition, MWCNT were 
observed penetrating the pleura (Porter et al. 2010). Next, morphometric measurements were 
used to investigate the distribution of MWCNT and the number of MWCNT penetrations of 
the alveolar epithelium, subpleural tissue defined as the alveolar epithelium immediately 
adjacent to the pleura, and intrapleural space defined as visceral pleural surface (Mercer et 
al. 2010). This study determined that at 56 days post-exposure, approximately one in every 
400 MWCNT was in either the subpleural tissue or intrapleural space, and numerous 
penetrations into macrophages in the alveolar airspaces were found at all post-exposure 
times. A recent report used morphometry to determine that the average thickness of 
connective tissue in the alveolar septa was increased over vehicle control by 45% in the 40 
μg and 73% in the 80 μg exposure groups at 56 days post-exposure, demonstrating that 
MWCNT have the potential to produce a progressive, fibrotic response in the alveolar 
tissues of the lungs (Mercer et al. 2011). Also, using Ingenuity Pathway Analysis (IPA), we 
determined that MWCNT exposure affects a subset of lung cancer biomarkers and identified 
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several carcinogenic-related signalling pathways that may be involved in the response 
(Pacurari et al. 2011). These studies, when considered together, provide compelling 
evidence that MWCNT may pose a significant human health risk.
In the present study, we continue our investigation of MWCNT in vivo lung toxicity by 
conducting an inhalation study. Specifically, mice were exposed to aerosolized MWCNT 
(10 mg/m3, 5 h/day) for 2, 4, 8 or 12 days, and pulmonary inflammation, damage and 
fibrosis were assessed at 1 day post-exposure. In addition, we measured lung burden and 
evaluated histopathologic changes in the nose, lung and tracheobronchial lymph node.
Materials and methods
MWCNT
MWCNT used in this study were obtained from Hodogaya Chemical Company (MWNT-7, 
lot #061220-31) and were manufactured using a floating reactant catalytic chemical vapour 
deposition method followed by high-temperature thermal treatment in argon at 2500°C 
using a continuous furnace (Kim et al. 2005).
High-resolution transmission electron microscopy
The MWCNT were observed under Philips CM 20 transmission electron microscope (TEM) 
equipped with EDS (EDAX/4pi). To prepare the TEM specimens, the MWCNT were 
dispersed into ethanol with the assistance of sonication. A droplet of this MWCNT 
suspension was then pipetted onto a carbon-coated copper grid and subsequently dried in 
ambient air at room temperature prior to TEM observation.
MWCNT trace metal analyses
To determine trace metals, bulk samples of MWCNT were digested by the nitric/perchloric 
acid ashing procedure (NIOSH 1994). The residues were dissolved in 10.0 ml of 4% 
HNO3-1% HClO4 for trace metals analysis by inductively coupled plasma-optical emission 
spectroscopy.
MWCNT endotoxin analyses
To determine endotoxin, bulk samples of MWCNT were prepared as 1.8 mg/ml suspensions 
in water. After rocking on a platform at room temperature for 24 h, the samples were 
centrifuged (5000 × g, 10 min, room temperature). Next, the samples were filtered using a 
0.45 μm syringe filter to remove any remaining particulate. Endotoxin analyses were done 
using the Limulus amebocyte lysate assay (Kinetic-QCL, BioWhittaker, Walkersville, MD).
XPS analyses of MWCNT
X-ray photoelectron spectroscopy (XPS) analyses were carried out with a PHI 5000 Versa 
Probe (Physical Electronics, MN). Prior to XPS measurement, the MWCNT were pressed to 
form a pellet. The pellet was then placed into the entry-load chamber and held in vacuum for 
6 h. A monochromated Al K radiation (1486.6 eV) was employed as X-ray source. Survey 
scans and high-resolution scans were collected at the pass energies of 94 and 58 eV, 
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respectively. The binding energies of spectra were referenced to the C 1s binding energy at 
284.6 eV for the carbon nanotubes.
ESR analyses of MWCNT
All ESR measurements were conducted using a Bruker Instruments (Billerica, MA) EMX 
ESR spectrometer and a flat cell assembly. Hyperfine couplings were measured (to 0.1 G) 
directly from magnetic field separation using potassium tetraperoxochromate (K3CrO8) and 
1,1 diphenyl-2-picrylhydrazyl (DPPH) as reference standards. The Acquisit program 
(Bruker Instruments, Billerica, MA) was used for data acquisition and analysis. Each assay 
sample consisted of 100 mM 5,5-dimethyl-1-pyrroline-N-oxide (DMPO), 0.1 or 1 mM 
FeSO4, 0.1 or 1 mM hydrogen peroxide (H2O2) and ± MWCNT (0.8 mg/ml) in a total 
volume of 1 ml of dispersion medium (Porter et al. 2008).
Animals
Male C57BL/6J mice (6 weeks old) were obtained from Jackson Laboratories (Bar Harbor, 
ME). Mice were housed one per cage in polycarbonate isolator ventilated cages, which were 
provided HEPA-filtered air, with fluorescent lighting from 0700 to 1900 h. Autoclaved 
Alpha-Dri virgin cellulose chips and hardwood Beta-chips were used as bedding. Mice were 
monitored to be free of endogenous viral pathogens, parasites, mycoplasms, Helicobacter 
and CAR Bacillus. Mice were maintained on Harlan Teklad Rodent Diet 7913 (Indianapolis, 
IN), and tap water was provided ad libitum. Animals were allowed to acclimate for at least 5 
days before use. All animals used in this study were housed in an AAALAC-accredited, 
specific pathogen-free, environmentally controlled facility. All procedures involving 
animals were approved by the NIOSH Institutional Animal Care and Use Committee.
MWCNT inhalation exposure and aerosol characterisation
Mice were exposed to a MWCNT aerosol (10 mg/m3, 5 h/day) for either 2, 4, 8 or 12 days, 
using an acoustical-based computer-controlled whole-body inhalation system designed and 
constructed by our laboratory (McKinney et al. 2009). In brief, the inhalation exposure 
system combines air flow controllers, aerosol particle monitors, data acquisition devices and 
custom software with automated feedback control to achieve constant and repeatable 
exposure chamber temperature, relative humidity, pressure, aerosol concentration and 
particle size distributions. The generator produces airborne particles continuously for long 
periods of time, e.g., 35 h of continuous operation, with minimal fluctuations during an 
exposure period. The uniformity of test atmosphere in the chamber was evaluated to have a 
total variation of <5%. In this study, the MWCNT aerosol mass concentration was 
continuously monitored with a Data RAM (DR-40000 Thermo Electron Co, Franklin, MA), 
and gravimetric determinations (37 mm cassettes with 0.45 μm pore-size Teflon filters) were 
used to calibrate and verify the Data RAM readings. In addition, a cascade impactor 
(MOUDI, Models 110 and 115, MSP Co., Shoreview, MN) was used to determine the mass- 
and number-based particle size distributions by fractionating the particles into 15 size 
fractions ranging from 10 nm to 18 μm. Particle morphology was also evaluated from 
Nucleopore polycarbonate filters (Whatman, Clinton, PA) obtained from the cascade 
impactor.
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MWCNT burden determination method was based on modification to a previous method for 
the determination of mouse and rat lung carbon black (Elder et al. 2005). After euthanasia, 
lungs were removed and wet weights obtained. The lung tissue was digested in 25% KOH/
methanol (w/v) at 60°C overnight, followed by centrifugation at 16,000 × g for 10 min. The 
supernatant was removed, the remaining pellet was mixed with 50% HNO3/methanol (v/v), 
and incubated at 60°C overnight, followed by centrifugation (16,000 × g, 10 min). The 
supernatant was removed, and the pellet resuspended in 10% NP-40 (v/v) in dH2O, followed 
by 30-sec sonication using a probe sonicator. MWCNT standards were processed in parallel 
with the lung samples. The optical densities of the solutions were measured at 700 nm using 
a UV/visible spectrophotometer. Lung MWCNT content was determined from a standard 
curve.
Whole lung lavage
At 1 day post-exposure, mice were euthanised with an i.p. injection of sodium pentobarbital 
(>100 mg/kg body weight) followed by exsanguination. A tracheal cannula was inserted, 
and whole lung lavage (WLL) was performed through the cannula using ice-cold Ca2+ and 
Mg2+-free phosphate buffered saline (PBS), pH 7.4, supplemented with 5.5 mM D-glucose. 
The first lavage (0.6 ml) was kept separate from the rest of the lavage fluid. Subsequent 
lavages, each with 1 ml of PBS, were performed until a total of 4 ml of lavage fluid was 
collected. WLL cells were isolated by centrifugation (650 × g, 5 min, 4°C). An aliquot of the 
acellular supernatant from the first WLL (WLL fluid) was decanted and transferred to tubes 
for analysis of lactate dehydrogenase (LDH) and albumin. The acellular supernatants from 
the remaining lavage samples were decanted and discarded. WLL cells isolated from the 
first and subsequent lavages for the same mouse were pooled after resuspension in PBS, 
centrifuged a second time (650 × g, 5 min, 4°C), and the supernatant decanted and 
discarded. The WLL cell pellet was then resuspended in PBS and placed on ice. Total WLL 
cell counts were obtained using a Coulter Multisizer 3 (Coulter Electronics, Hialeah, FL) 
and cytospin preparations of the WLL cells were made using a cytocentrifuge (Shandon 
Elliot Cytocentrifuge, London). The cytospin preparations were stained with modified 
Wright-Giemsa stain, and cell differentials were determined by light microscopy.
WLL fluid LDH, albumin and cytokine measurement
WLL fluid albumin concentrations were determined as an indicator of the integrity of the 
alveolar air–blood barrier. WLL fluid albumin was determined colorimetrically at 628 nm 
based on albumin binding to bromcresol green, using a commercial assay kit (Sigma 
Chemical Company, St. Louis, Mo). WLL fluid LDH activities were evaluated as a marker 
of cytotoxicity. WLL fluid LDH activities were determined by monitoring the LDH-
catalysed oxidation of lactate to pyruvate coupled with the reduction of NAD at 340 nm 
using a commercial assay kit (Roche Diagnostics Systems, Montclair, NJ). Both the WLL 
fluid albumin and LDH assays were conducted using a COBAS MIRA Plus (Roche 
Diagnostic Systems, Montclair, NJ). The chemokine KC, which is a neutrophil 
chemoattractant, was determined in first WLL fluid using a commercial ELISA assay kit 
(AushonBiosystems, Billerica, MA).
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Following euthanasia, the lung, tracheobronchial lymph node and nose were rapidly 
removed. The lung was fixed by airway inflation with 6 cc of 10% neutral buffered 
formalin. The tracheobronchial lymph node and the nose were immersion fixed in 10% 
neutral buffered formalin. The lung and lymph node were trimmed on the day of necropsy, 
processed overnight and embedded in paraffin. The nose was decalcified in 13% formic acid 
and sectioned at three levels as previously described (Herbert & Leininger 1999; Young 
1981). A fourth level, further back in the nose, was included for a more complete assessment 
of nasal changes. Sections from the left lung lobe, tracheobronchial lymph node and nose 
were stained with hematoxylin and eosin for routine pathology evaluation. In addition, the 
sections of left lung lobe were stained with Masson’s trichrome to evaluate fibrosis and with 
alcian blue/periodic acid-Schiff to evaluate mucosubstances (American Registry of 
Pathology 1968). Sections of lung and lymph node were examined at the 4-, 8- and 12-day 
time points, and sections of nose were examined at the 12-day time point.
Slides were interpreted by a board-certified veterinary pathologist (AFH). Semi-quantitative 
histopathology scores were assigned for major categories of lung and nose histopathology 
changes as previously described (Hubbs et al. 2008). In brief, a severity score was assigned 
to quantify the severity of the response (where none = 0, minimal = 1, mild = 2, moderate = 
3, marked = 4 and severe = 5) and a distribution score was assigned to quantify how that 
change was distributed within the lung (where none = 0, focal = 1, locally extensive = 2, 
multifocal = 3, multifocal and coalescent = 4 and diffuse = 5). The pathology score was the 
sum of the severity and distribution scores. Due to the compartmental nature of hyperplasia 
and particle translocation in the tracheobronchial lymph node, only the severity score was 
used as a quantitative measure (where none = 0, minimal = 1, mild = 2, moderate = 3, 
marked = 4 and severe = 5) with a notation of the affected compartment where appropriate 
(e.g., paracortical). Cytopathologic changes associated with penetration of cellular 
membranes by MWCNT and phagocytosis of apopototic cells were qualitatively evaluated 
at 100× magnification in hematoxylin and eosin-stained sections of lung, nose and lymph 
node.
Augmented microscopic imaging
To further document MWCNT penetration of the pleura, H&E-stained sections from 
MWCNT-exposed mice in the 12-day time point were examined using enhanced-darkfield 
light microscopy using illumination optics designed for visualisation of refractive 
nanoparticles and an Olympus BX-41 microscope (CytoViva, Auburn, AL) as previously 
described (Mercer et al. 2011). Enhanced-darkfield light microscopy was also used for 
visualisation of cells obtained by WLL from MWCNT-exposed mice at the 12-day time 
point.
Additional sections of the left lung lobe from the 12-day time point were stained with 
ethidium homodimer-1, a nucleic acid stain, and for lamin B1, a nuclear membrane protein 
and imaged by confocal microscopy. While ethidium homodimer-1 is cell impermeant, 
nuclei of fixed tissues can be stained by cell permiabilisation techniques to take advantage 
of the intense nuclear staining produced by this fluorescent dye. Therefore, for the ethidium 
Porter et al. Page 6













homodimer-1 and lamin B1 stain, deparaffinised sections were permiabilised and 
antigenicity was retrieved by microwaving in 1 mM EDTA. Non-specific staining was 
blocked with 10% donkey serum. The slides were incubated with a 1:670 dilution of rabbit 
anti-lamin B1 (product PA5-19468, Thermo Scientific, Rockford, IL) for 8 min at room 
temperature. The secondary antibody was Alexa 488 donkey anti-rabbit (Molecular Probes/
Invitrogen, Eugene, OR). After rinsing, the slides were incubated with ethidium 
homodimer-1 (1 μM) for 45 min to stain nuclei.
Lamin B1 and ethidium homodimer-1-stained sections were imaged using a Zeiss laser 
scanning confocal microscope (LSM 510, Carl Zeiss microscopy, Thornwood, NY). Foci 
with MWCNT deposition were identified using transmitted light. Ethidium homodimer-1 
and lamin B1 staining were identified by fluorescence and precise localisation of MWCNT 
in optical sections was done using reflected light and multi-tracking with Zen 2009 software. 
Using the live imaging feature, serial 0.8 μm optical sections were examined until MWCNT 
localisation was confirmed in the nucleus. The optical section with nuclear MWCNT was 
then saved as a high-resolution image.
Statistics
All outcomes yielding quantitative values were analysed with parametric analysis of 
variance (ANOVA). This was performed using an unequal variance model available in SAS 
PROC MIXED. Ordinal measurements resulting from histopathology were analysed with 
non-parametric ANOVA. This was performed using the SAS procedure PROC 
NPAR1WAY with an exact Kruskall-Wallis test to account for ties in the data. All statistical 
tests in this study are two-tailed with an alpha = 0.05 significance level.
Results
Characterisation of Bulk MWCNT
High-resolution transmission electron microscopy (TEM) images of bulk MWCNT showed 
the distinctive crystalline structure of MWCNT (Figure 1). The bulk MWCNT samples were 
measured by XPS. The survey-scan spectrum obtained from the MWCNT sample (Figure 
2A) shows that there was a dominant C 1s peak and a very small oxygen peak. No other 
elements were found by XPS measurements. In the detailed-scan XPS spectrum (Figure 2B) 
of the C 1s core level, the peak at 284.6 eV could be assigned to the sp2-bonded carbon 
atoms. The peaks at 285.0 and 286.2 eV indicates the presence of a small amount of –C-OH 
group. Trace metal contamination of aerosolized MWCNT was 1.32%, with iron (1.06%) 
being the major metal contaminant.
Electron spin resonance (ESR) studies
Acellular electron spin resonance (ESR) experiments were conducted to determine if 
MWCNT produced reactive oxygen species (ROS). The Fenton reaction (Fe2+ + H202 → 
Fe3+ + •OH + −OH) was used as a source of •OH radicals. An aqueous solution containing 
Fe2+, H2O2 and a spin trap (DMPO) in PBS (pH 7.4) generated a 1:2:2:1 quartet with 
hyperfine splittings of 15 G (Figure 3A). Based on these splitting constants, the 1:2:2:1 
quartet was assigned to a DMPO/•OH adduct as an indirect evidence for •OH generation. 
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When DM was used as the aqueous buffer instead of PBS, the ESR signal was essentially 
identical to that in PBS (Figure 3B). Addition of MWCNT to the reaction mixture decreased 
the ESR signal, indicating that MWCNT were scavenging •OH being generated from the 
Fenton reaction (Figure 3C). Finally, when MWCNT were substituted for Fe2+ in the 
reaction, no •OH generation was detected, indicating the iron present in MWCNT was not 
capable of generating measurable ROS (Figure 3D), presumably because the iron is 
encapsulated by carbon.
Aerosol mass concentration
Previously, we have successfully used the acoustical-based computer-controlled system to 
generate a stable MWCNT aerosol for animal exposures, and demonstrated that it is capable 
of maintaining a mean aerosol concentration to within 0.1 mg/m3 of the selected aerosol 
concentration target value (McKinney et al. 2009). In this study, the MWCNT aerosol mass 
concentration was continuously monitored with a Data RAM, and gravimetric 
determinations with Teflon filters were used to calibrate and verify the Data RAM readings. 
The mass concentration had a daily range of 8.8–10.9 mg/m3, not including the initial rise 
time and fall time during the start and end of each exposure, with a mean and standard 
deviation of 10.02 ± 0.35 mg/m3 throughout the study.
Particle morphology
Particle morphology of MWCNT aerosol samples from our exposure chamber was analysed 
by TEM (Figure 4A) and field emission scanning electron microscopy (FESEM) (Figure 
4B). The images indicated a diverse configuration of MWCNT particle shapes ranging from 
single fibre-like nanotubes to tangled agglomerates.
Particle size distribution
The MOUDI cascade impactor was used to determine the mass-and number-based particle 
size distribution of the MWCNT aerosol in the exposure chamber. However, while the mass-
based size distribution had a peak on the sixth stage of the MOUDI samples by gravimetric 
measurements, the number-based distribution revealed a peak on the eighth stage of the 
samples by visually inspecting the filters under a TEM (Figure 5). The results indicate a 
mass mode aerodynamic diameter of 1.3 μm and a count mode aerodynamic diameter of 
0.42 μm. Figure 6 shows a typical size distribution of MWCNT particles collected from the 
chamber (M = mass concentration and Dae = aerodynamic diameter). When characterised by 
log normal statistics, the distribution had a mass median aerodynamic diameter (MMAD) of 
1.5 μm and geometric standard deviations (GSD) of 1.67.
MWCNT lung burden and distribution
MWCNT exposure resulted in significantly increased lung burdens at each exposure time 
(Figure 7). The MWCNT lung burden was linearly related to exposure duration, ranging 
from 6.6 ± 0.5 to 30.6 ± 1.2 μg/lung after 2 and 12 days of exposure, respectively. The 
distribution of MWCNT in mice with a lung burden of 13.0 μg (4 days exposure) was 
determined one day after the exposures were concluded. No MWCNT were observed in air-
exposed controls (Figure 8A), whereas MWCNT were observed in the bronchioles and 
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proximal alveolar region of MWCNT-exposed mice (Figure 8B). Morphometric analyses 
determined that the airways had 24% of the total lung burden, of which 11.7% was in the 
airspace, 4.5% was in the tissue and 8.1% was in the macrophages (Figure 8C). The alveolar 
region had 76% of the total lung burden, which was distributed 14.6% in the airspace, 11.9% 
in the tissue and 49.2% in the macrophages (Figure 8C). Finally, MWCNT were also 
observed at the pleural wall (Figure 8D).
Pulmonary inflammation and damage
MWCNT-induced pulmonary inflammation was assessed by determining WLL 
polymorphonuclear leukocytes (PMN) (Figure 9A). All MWCNT-exposed mice had 
significantly higher WLL PMN levels in comparison to the air-exposed mice. In addition, 
inflammation was dose dependent, i.e., mice with 23 μg MWCNT exhibited significantly 
greater inflammation than mice with 7 and 13 μg MWCNT lung burdens. Furthermore, 
WLL PMN levels for mice with 31 μg MWCNT lung burdens was higher than that for mice 
with 23 μg MWCNT lung burdens, although this increase was not statistically significant. 
The chemokine KC, which is a neutrophil chemoattractant, was determined in WLL fluid 
(Figure 9B). All MWCNT-exposed mice had significantly higher WLL fluid KC 
concentrations in comparison to corresponding air-exposed controls. In MWCNT-exposed 
mice, WLL fluid KC concentrations exhibited a significant increase as MWCNT lung 
burden increased.
MWCNT-induced cytotoxicity in the lung was assessed by determining WLL fluid LDH 
activities (Figure 10A). All MWCNT-exposed mice had significantly higher WLL fluid 
LDH activities versus corresponding air-exposed controls. LDH activities were not 
significantly different between mice with MWCNT lung burdens of 23 and 30 μg, but a 
significant dose-dependent increase was observed for mice with lung burdens between 7 and 
23 μg MWCNT.
WLL fluid albumin concentrations were determined as a marker of the integrity of the 
alveolar air–blood barrier (Figure 10B). All MWCNT-exposed mice had significantly higher 
WLL fluid albumin concentrations in comparison to air-exposed controls. WLL fluid 
albumin concentrations exhibited dose-dependence for mice with lung burdens ranging from 
7 to 23 μg, but no statistically significant difference in WLL fluid albumin was present 
between mice with 23 and 30 μg MWCNT lung burdens.
Histopathology
In the lung, histopathologic alterations were principally characterised by (1) inflammation 
centered at the bronchioloalveolar junction, (2) hyperplasia and hypertrophy of the 
bronchiolar epithelium, (3) airway mucous metaplasia, (4) fibrosis and (5) vascular changes 
(Table I). In addition, the pleura of two mice were penetrated by MWCNT.
Lung inflammation identified by histopathology was associated with deposition of MWCNT 
(Figures 11A, 11B). As noted above, MWCNT were most frequently deposited in 
bronchioles and the proximal alveolar regions. Thus, pulmonary inflammation was centred 
near the bronchioloalveolar junction. At all time points, the principal inflammatory cells 
were consistently macrophages and neutrophils. Giant cells were first observed at the 8-day 
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exposure time point and were an occasional component of the inflammatory response in five 
of six MWCNT-exposed mice at the 8-day time point and six of six MWCNT-exposed mice 
at the 12-day time point. Giant cells were not seen in the lungs of control mice. One 
MWCNT-exposed mouse at the 12-day time point had multifocal moderate eosinophilic 
crystalline pneumonia, a condition associated with spontaneous or treatment-associated 
accumulations of YM1 protein in mice (Hoenerhoff et al. 2006).
MWCNT-induced cytopathology was observed in lung macrophages. Those changes 
included penetration of the cytoplasmic and nuclear membrane. Focal nuclear rarefaction 
and/or chromatin condensation was sometimes observed in association with penetration of 
the nuclear membrane. In addition, some macrophages containing MWCNT had no visible 
nucleus or decreased nuclear staining consistent with karyolysis. One dividing macrophage 
had MWCNT incorporated into an abnormal mitotic figure (Figure 11C), a change 
reminiscent of those previously reported after exposure to single-walled carbon nanotubes 
(Sargent et al. 2012; Shvedova et al. 2008). Confocal microscopy of lamin B1 and ethidium 
homodimer-1 stained sections as well as enhanced-darkfield light microscopic imaging 
confirmed penetration of rare nuclei by MWCNTs (Figures 12A, B and C).
Bronchiolar epithelial cell hypertrophy and hyperplasia were present in all MWCNT-
exposed mice at all time points (Table I, Figure 11B). Mitotic figures in the airway 
epithelium, while rare, were seen in all MWCNT-exposed mice at the 4-day time point and 
thereafter were observed in only one mouse in the 12-day MWCNT exposure group. Rare 
intraepithelial MWCNT were seen in seven of eight mice after 4 days of MWCNT exposure 
and two of six mice after 8 days of MWCNT exposure (Figure 11D). Intraepithelial 
MWCNT were not seen in mice exposed to MWCNT for 12 days.
Mucous metaplasia of airway epithelial cells was observed in seven of eight MWCNT-
exposed mice at the 4-day exposure time point. At the 8- and 12-day time points, mucous 
metaplasia was observed in all MWCNT-exposed (Table I, Figure 11E).
Lung fibrosis was generally minimal to mild in severity, principally bronchiolocentric and 
was associated with sites of inflammation in the lungs of all MWCNT-exposed mice at the 
8- and 12-day time points. In addition to being associated with inflammation, fibrosis was 
associated with an expanded interstitium and the presence of interstitial MWCNT (Figure 
11F).
Vascular changes were consistently observed in the lungs of MWCNT-exposed mice 
although affected vessels were rare within each section. The features of vascular changes 
varied and include medial hypertrophy and contraction, mural neutrophil infiltrates and rare 
mural MWCNT (Table I, Figure 11G).
Pleural penetration was seen in two mice, both from the 12-day time point. In one of these 
mice, MWCNT extended from the pleura into a macrophage on the pleural surface (Figure 
11H). Pleural penetration was confirmed using enhanced darkfield light microscopy (Figure 
12D).
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In the tracheobronchial lymph nodes, histopathologic alterations were principally 
characterised by (1) translocation of MWCNT and (2) expansion of the deep paracortex. 
Tracheobronchial lymph nodes of the mouse are extremely small, but adequate samples for 
histopathologic evaluations were available for four of eight control mice and seven of eight 
MWCNT-exposed mice at the 4-day time point, four of six control mice and two of six 
MWCNT-exposed mice at the 8-day time point, and three of six control mice and five of six 
MWCNT-exposed mice at the 12-day time point. MWCNT were identified in lymph nodes 
of five MWCNT-exposed lymph nodes after 4 days of exposure and in all MWCNT-
exposed mice after 8 and 12 days of exposure. The MWCNT in the lymph node were 
predominantly localised to deep paracortical region that was expanded in three of seven 
MWCNT-exposed lymph nodes after a 4-day exposure and in all MWCNT-exposed lymph 
nodes after 8 or 12 days of exposure (Table II, Figure 13). In the paracortex, cells containing 
MWCNT were morphologically consistent with macrophages and dendritic cells. Cells 
containing both MWCNT and apoptotic debris were also observed. Cytopathology changes 
include penetration of the nuclear membrane with associated nuclear rarefaction and/or 
chromatin condensation (Figure 14).
In the nose, the principal histopathologic alteration after the 12-day exposure was 
neutrophilic inflammation (Table III). Neutrophilic inflammation was present in level T1 in 
five of six MWCNT-exposed mice. In level T2 and level T3, neutrophilic inflammation was 
present in all MWCNT-exposed mice. In level T4, neutrophilic inflammation was present in 
four of six MWCNT-exposed mice. In addition, intraepithelial hyaline droplets were seen in 
the respiratory epithelium of the nose of all MWCNT-exposed mice and affected levels T2 
(five of six mice), T3 (six of six mice) and T4 (six of six mice). MWCNT were seen in nasal 
sections from four mice. In two mice, intraepithelial MWCNT were observed and MWCNT 
were seen in the mucous layer of four mice.
Discussion
The primary objective of this investigation was to evaluate MWCNT-induced pulmonary 
inflammation, damage and fibrosis 1 day post-exposure to an aerosol of MWCNT. To 
accomplish this, mice were exposed to aerosolized MWCNT (10 mg/m3, 5 h/day) for either 
2, 4, 8 or 12 days. At 1 day post-exposure, MWCNT lung burdens ranged from 7 μg (2 days 
exposure) to 31 μg (12 days exposure). In order to evaluate the relationship of these 
MWCNT lung burdens to human MWCNT exposures, we determined if the MWCNT lung 
burdens in these mice are relevant human occupational exposures.
Data on human exposures to MWCNT are limited in number and in regards to the exact 
levels of MWCNT in the airborne samples. The first study reported workplace MWCNT-
containing airborne dust levels of approximately 400 μg/m3 in a research laboratory (Han et 
al. 2008), while a later study reported a peak total particle concentration of 320 μg/m3 with a 
mean of 106 μg/m3 based on results obtained from monitoring total workplace dust levels at 
seven MWCNT facilities (Lee et al. 2010). However, both studies may have overestimated 
MWCNT exposure because the MWCNT structures observed in the research laboratory 
varied between agglomerates to individual fibres, and not all of the particles were MWCNT 
(Han et al. 2008), while samples from the seven MWCNT facilities included significant 
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amounts of metal nanoparticles used as catalyst for MWCNT production (Lee et al. 2010). 
However limited these workplace exposure studies may be, they currently are the only ones 
available to evaluate if the MWCNT lung burdens measured in this study are relevant to 
human occupational exposures.
Assuming a mouse alveolar epithelium surface area of 0.05 m2 (Stone et al. 1992), the 7 μg 
MWCNT lung burden would result in 140 μg MWCNT/m2 alveolar epithelium, whereas the 
31 μg MWCNT lung burden would result in 620 μg MWCNT/m2 alveolar epithelium. Using 
the MWCNT MMAD = 1.5 μm, minute ventilation of 20 L/min for a person performing 
light work (Galer et al. 1992), deposition fraction of 30% (Phalen 1984) and human alveolar 
epithelium surface area of 102 m2 (Stone et al. 1992), approximate human lung burden per 
month for a workplace MWCNT exposure of 106 or 400 μg/m3 (Han et al. 2008; Lee et al. 
2010) would be 60 and 226 μg MWCNT/m2 alveolar epithelium, respectively. Thus, 17 μg 
MWCNT lung burden in mouse approximates human deposition for a person performing 
light work for 2.5 – 5 months, while the 77 μg MWCNT lung burden in mice approximates 
human deposition for a person performing light work for 8 – 25 months. As previously 
stated, the two studies which have reported human MWCNT exposures likely have 
overestimated MWCNT exposure levels. If we assume actual human average, daily 
MWCNT aerosol exposure may be 10 times lower (10–40 μg/m3 MWCNT) than estimates 
based on total airborne dust levels of 106 and 400 μg/m3 (Han et al. 2008; Lee et al. 2010), 
the 31 μg MWCNT lung burden in mouse would approximate human deposition for a person 
performing light work for approximately 27-103 months, i.e., 2.3–8.5 years. Thus, these 
estimates suggest that the mouse MWCNT lung burdens in this study approximate feasible 
human occupational exposures.
A panel of experts has recommended the characterisation of both “as-produced” and “as-
administered” nanoparticles used in toxicological studies (Oberdorster et al. 2005), and later 
it was suggested that nanotoxicology studies that lack adequate nanoparticle characterisation 
may not provide meaningful data or conclusions (Warheit 2008). Although the manufacturer 
of MWCNT used in these studies was the same as in our earlier study (Porter et al. 2010), it 
was necessary to use a different lot of MWCNT for the present study. Because lot-to-lot 
variation is a potential confounding factor in interpreting the results, using the guidance 
from experts in nanotoxicology (Oberdorster et al. 2005; Warheit 2008), we invested 
significant effort into the characterisation of the MWCNT used in this study so that the 
results could be compared to our previous in vivo study (Porter et al. 2010) as well as data 
reported by others.
The bulk sample of MWCNT was analysed using several different techniques: (1) high-
resolution TEM, (2) XPS and (3) ESR spectroscopy. High-resolution TEM determined that 
the nanoparticles used in this study were MWCNT, and not some other form of 
carbonaceous material. XPS analyses determined a C 1s peak at 284.6 eV, which 
corresponds to the sp2-hybridised graphite-like carbon atoms (Ago et al. 1999; Chen et al. 
1999). The C 1s peak at 285 eV is attributed to the sp3-hybridised carbon atoms with 
disordered structure (Pinault et al. 2005), whereas the C 1s peak component at 286.2 eV is 
attributed to C–O bonds (Felten et al. 2006; Stankovich et al. 2006). The later observation 
indicates the formation of the hydroxyl groups on the MWCNT surface (Felten et al. 2006). 
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The XPS analyses of the MWCNT used in this study were very similar to those reported by 
our laboratory using a different lot of MWCNT from the same manufacturer (Porter et al. 
2010). Aerosol samples of the MWCNT were collected and analysed for 31 different metals 
because metals are used as catalysts for MWCNT synthesis and can remain as contaminates 
post-production in MWCNT. The metal analyses determined the total metal content was 
relatively low, 1.32%, with iron (1.06%) being the major contaminant.
Intracellular ROS production after exposure to SWCNT or MWCNT has been demonstrated 
with NR8383 and A549 cells, an observation which suggests that exposure to CNT induces 
cellular oxidative stress (Pulskamp et al. 2007). Acid treatment of the CNT used in that 
study prior to exposure resulted in reduction of CNT-induced cellular oxidative stress, which 
led to the suggestion that metal contaminants in the CNT samples, and not the CNTs 
themselves, were responsible for the cellular oxidative stress response (Pulskamp et al. 
2007). However, we had to at least consider the possibility that the MWCNT in this study 
may induce oxidant production despite the low metal contamination of the MWCNT used in 
the present study. Cell-free ESR experiments determined that MWCNT did not generate 
ROS. These findings are consistent with previous studies, which also determined that cell-
free aqueous suspensions of MWCNT do not generate ROS (Fenoglio et al. 2006; Porter et 
al. 2010). It should also be noted that the MWCNT scavenged ROS to a small degree, which 
is similar to earlier findings using MWCNT from a different manufacturer (Fenoglio et al. 
2006) and from our laboratory using a different lot of MWCNT from the same manufacturer 
(Porter et al. 2010).
The system used to generate MWCNT aerosols in this study has been previously described 
in detail (McKinney et al. 2009). Gravimetric determinations indicated the MWCNT mean 
mass concentration per exposure was 10.02 ± 0.35 mg/m3 (mean ± SD). The mass- and 
number-based particle size distribution of the MWCNT aerosol in the exposure chamber 
was examined using a MOUDI cascade impactor. These analyses determined a mass mode 
aerodynamic diameter of 1.3 μm and a count mode aerodynamic diameter of 0.42 μm. The 
distribution had a MMAD of 1.5 μm and a GSD of 1.67. MWCNT morphology, analysed by 
TEM and SEM, found a diversity of particle shapes and configurations. Most importantly, 
these images are similar to those published in a recent report in which samples were 
collected from the breathing zones in a MWCNT manufacturing workplace (Han et al. 
2008). This indicates that the particle size and shape of these workplace samples appear to 
be very similar to the samples collected in our exposure chamber, thus demonstrating that 
our aerosol generation system produced MWCNT aerosols representative of those occurring 
in a workplace. In addition, there is a striking similarity between aerosolized MWCNT 
structures generated in the present study and structures in the dispersed suspension of 
MWCNT used in a previous pharyngeal aspiration study by our laboratory (Porter et al. 
2010).
The lung burdens in this inhalation study, which ranged from 7 to 31 μg MWCNT, were 
similar to the doses used in our previous MWCNT aspiration study of 10–40 μg (Porter et al. 
2010). The distribution of MWCNT in mice with a lung burden of 13.0 μg (4 days exposure) 
was assessed and indicated that MWCNT were deposited in both the alveolar and airway 
regions of the lung. The largest deposition was in the AM in the alveolar region, suggesting 
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that the inhaled MWCNT were being phagocytised and the process of clearance from the 
lung had been initiated. The MWCNT in the airways may have resulted from direct 
deposition from the aerosol, as well as AM moving up the mucociliary escalator as part of 
the clearance process. In addition, our laboratory has previously reported that after 
pharyngeal aspiration of MWCNT, MWCNT penetrated the pleura (Porter et al. 2010; 
Mercer et al. 2010). Lastly, our laboratory has previously reported that 56 days after 
pharyngeal aspiration to MWCNT that inflammation had extended to the pleura, and 
MWCNT had penetrated the pleura. Here we report similar data obtained from mice one day 
after completion of a 4-day aerosol exposure to MWCNT, i.e., two mice had pleural 
penetration after 12 days of MWCNT inhalation. This result adds further weight to the 
hypothesis that MWCNT, if persistent in the lung, could cause diseases that are reminiscent 
of the classic inhalable occupational fibre: asbestos (Donaldson et al. 2006; Donaldson & 
Tran 2004).
MWCNT-induced pulmonary inflammation was assessed by determining WLL PMNs, and 
indicated significant inflammation was induced by exposures of varying durations and lung 
burdens. Furthermore, MWCNT-induced pulmonary inflammation in WLL was biphasic, 
i.e., inflammation induced by MWCNT lung burdens of 7 and 13 μg was similar, while that 
induced by MWCNT lung burdens of 23 and 31 μg increased further. This biphasic response 
may be due to an increase in lung neutrophil chemoattractant KC, which increased with 
increasing MWCNT lung burden. Thus, it appears that pulmonary neutrophilic inflammation 
is caused by both MWCNT deposition as well as the expression of inflammatory mediators, 
such as KC. Semi-quantitative histopathology assessment of lung inflammation is a less 
quantitative measure than WLL but confirmed the presence of persistent inflammation in the 
lung, involvement of the pulmonary interstitium and the development of fibrosis in some 
foci of interstitial inflammation. In addition, airway mucous metaplasia was demonstrated in 
histologic sections. Since mucous metaplasia is a known response of airway epithelial cells 
to a variety of cytokines, this change was consistent with the persistent inflammation 
demonstrated by histopathology and WLL.
It was expected that MWCNT exposure might also result in some cytotoxic damage in the 
lung. To measure this, MWCNT-induced cytotoxicity, measured by WLL fluid LDH, and 
permeability of the alveolar air–blood barrier, as measured by WLL fluid albumin, was 
determined, respectively. In contrast to the biphasic nature of the lung inflammatory 
response, these parameters of toxicity had a nearly linear response to MWCNT lung burden. 
This suggests that these parameters of lung toxicity are being influenced most directly by the 
amount of MWCNT deposited in the lung. Another occupationally important dust, silica, 
induces cytotoxic damage to the lung via particle-induced ROS generation (Vallyathan et al. 
1995) and/or cellular-mediated ROS generation (Blackford et al. 1994). The ESR studies 
reported here determined MWCNT do not generate ROS, making it unlikely that the 
cytotoxic damage resulted from direct MWCNT-mediated ROS. However, MWCNT-
induced cellular-mediated ROS production has been reported (Pulskamp et al. 2007), and 
this may contribute to the observed cytotoxicity. The presence of airway mucous metaplasia 
in the MWCNT-exposed mice in our study is consistent with the presence of cell-mediated 
cytotoxic damage, because mucous metaplasia can be a response to a variety of cytokines 
(Young et al. 2007; Lai & Rogers 2010). Furthermore, the interaction of MWCNT with the 
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alveolar epithelial cells noted in the FESEM images and histopathology sections may also 
impact both LDH release and increased permeability of the alveolar air–blood barrier.
A previous MWCNT inhalation study exposed mice to aerosols of either 1 or 30 mg/m3 
MWCNT for 6 h (Ryman-Rasmussen et al. 2009b). The calculated dose for the mice 
exposed to 30 mg/m3 MWCNT for 6 h falls within the range of MWCNT lung burdens 
determined in the present study. Data presented in the Ryman-Ramussen et al. study 
indicated that inhaled MWCNT were contained in macrophages; these macrophages 
migrated to the subpleural region and significant subplueral fibrosis was observed. 
Furthermore, the authors speculated the activated macrophages containing MWCNT travel 
through the pleural lymphatics. Micron-sized particles have been demonstrated to move 
from the alveolar region of the lung to the draining lymph nodes within macrophages and 
neutrophils (Harmsen et al. 1987; Harmsen et al. 1985). Small spherical nanoparticles less 
than 34 nm in diameter can be transported from the alveolar region to the draining lymph 
nodes within minutes of administration suggesting that the lymphatic transport of the 
smallest nanoparticles may not require phagocytosis (Choi et al. 2010). Indeed, it has 
previously been noted that many nanomaterials are preferentially transported in the 
lymphatics (Riviere 2009). In the present study, we demonstrated intracellular MWCNT on 
the surface of the pleura (Figure 11H) and multiple MWCNT in lymph nodes (Figure 14), 
observations supporting the hypothesis that activated macrophages containing MWCNT 
travel through the lymphatics and reach the pleura.
Translocation of MWCNT from the lung to the tracheobronchial lymph node has previously 
been demonstrated in rats (Aiso et al. 2011). Increased paracortical cellularity has also been 
previously noted in the lymph nodes of rats inhaling MWCNT (Pauluhn 2010). Decreased 
T-cell-dependent immunologic responses have previously been observed in mice inhaling 
MWCNT (Mitchell et al. 2007), a response that has been proposed to be mediated 
predominantly via transforming growth factor-β release from MWCNT-exposed lungs 
(Mitchell et al. 2009). In the present study, we identified translocation of MWCNT from the 
lung to the tracheobronchial lymph nodes in the mouse. Translocation of MWCNT to the 
lymph nodes was accompanied by lymph node enlargement with hyperplasia principally in 
the deep paracortical units of the lymph node. Thus, our study confirms that in the mouse as 
well as the rat, the draining lymph nodes are a site for MWCNT clearance from the lung and 
that the lymph node responds to the presence of the translocated MWCNT by hyperplasia. 
The deep paracortical units of the lymph node are preferentially occupied by dendritic cells 
and T-lymphocytes, and are sites of interaction between antigen-presenting cells and T-
lymphocytes (Willard-Mack 2006), suggesting that MWCNT translocation to the deep 
paracortical units of the lymph node we observed in our study may alter T-cell responses, 
either locally or through release of mediators.
A long-standing issue in pulmonary toxicology is the relevance of bolus exposure to 
particles by intratracheal instillation or pharyngeal aspiration to pulmonary responses 
resulting from inhalation exposure (Henderson et al. 1995). The results of the present short-
term MWCNT inhalation study afford a unique opportunity to address this issue, since the 
MWCNT pharyngeal aspiration study previously reported by our laboratory (Porter et al. 
2010) used similar material at nearly equivalent lung burdens, and measured the same end 
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points over the same post-exposure time. Additionally, the structure sizes generated by 
aerosolization of dry MWCNT in the present study were strikingly similar to those obtained 
when MWCNT were suspended in dispersion medium (Porter et al. 2008), which represents 
a diluted artificial alveolar lining fluid. Since the MWCNT used and the experimental design 
of the present inhalation study and our previous aspiration study when MWCNT were 
suspended in dispersion medium (Porter et al. 2010) are similar, one can compare the 
inflammatory and damage responses at a given lung burden 1 day after exposure. As shown 
in Figure 15, the degree of infiltration of PMNs into the airspaces after aspiration does not 
significantly differ from the inflammatory response after inhalation of MWCNT.
It has also been argued that inhalation exposure results in a more even distribution of 
particles throughout the lung, while bolus exposure creates deposition hot spots (Henderson 
et al. 1995). However, mice exposed to fluorescent beads by pharyngeal aspiration exhibited 
a relatively uniform distribution of particles throughout the various lung lobes (Rao et al. 
2003). Morphometric analysis of MWCNT distribution after pharyngeal aspiration from a 
study conducted by our laboratory (Porter et al. 2010) reported that 1 day after aspiration, 
18% of MWCNT structures were in the airways, while 81% were in the alveolar region of 
the lung (Mercer et al. 2010). Morphometric data in the present study found very similar 
results indicating that 1 day after inhalation of MWCNT 24% of structures were in the 
airways, while 76% were in the alveolar region. Additionally, MWCNT were found to reach 
the subpleural tissue after both inhalation (present study) and pharyngeal aspiration (Mercer 
et al. 2010; Porter et al. 2010). Therefore, aspiration of a well-dispersed suspension of 
MWCNT appears to result in a pulmonary distribution which models closely that seen after 
inhalation of a similar lung burden of MWCNT.
Finally, NIOSH (NIOSH 2010) conducted a risk analysis to compare benchmark human 
exposure concentration for MWCNT using data from a mouse aspiration study (Porter et al. 
2010) versus a 3-month inhalation study (Ma-Hock et al. 2009). Benchmark exposure 
concentration for MWCNT-induced pulmonary fibrosis or granulomatous inflammation was 
0.61 μg/m3 for the aspiration versus 0.5 ug/m3 for the inhalation study, respectively. 
Therefore, evidence indicates that when CNT samples of similar dispersion are used, 
aspiration studies can predict a pulmonary response that is consistent with short-term 
inhalation studies when dosed at an equal mass lung burden.
In summary, the data reported here indicate that the lung burdens of MWCNT in this study 
represent lung burdens relevant to estimated human occupational exposures and caused 
dose-dependent pulmonary inflammation and damage, as assessed by WLL and 
histopathological methods. MWCNT exposure also caused rapid development of pulmonary 
fibrosis. Furthermore, the data demonstrate that MWCNT can reach and penetrate the pleura 
after aerosol exposure, confirming earlier findings by our laboratory (Porter et al. 2010; 
Mercer et al. 2010) that this occurred after pharyngeal aspiration exposure to MWCNT. 
However, the possible development of adverse health outcomes resulting from MWCNT 
reaching, and in some cases penetrating, the lung pleura still requires further investigation.
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High-resolution transmission electron micrograph of MWCNT. A representative high-
resolution transmission electron micrograph of the bulk MWCNT sample shows the 
distinctive crystalline structure of MWCNT.
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XPS spectra of MWCNT. (Panel A) XPS survey-scan spectrum has a dominant carbon (C 
1s) peak and a small oxygen (O 1s) peak. (Panel B) The detailed-scan XPS spectrum of the 
C 1s core level determined a C 1s peak at 284.6 and 285 eV, which corresponds to the sp2-
hybridised graphite-like carbon atoms of the carbon nanotube and the sp3-hybridised carbon 
atoms with disordered structure, respectively. The C 1s peak component at 286.2 eV is 
attributed to the C–O bond, indicating the formation of the hydroxyl groups on the MWCNT 
surface.
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ESR study of MWCNT. (Panel A) PBS with 100 mM DMPO + 0.1 mM FeSO4 + 1 mM 
H2O2. (Panel B) DM with 100 mM DMPO + 0.1 mM FeSO4 + 1 mM H2O2. (Panel C) DM 
with 100 mM DMPO + 0.1 mM FeSO4 + 1 mM H2O2 + 0.8 mg/ml MWCNT. (Panel D) DM 
with 100 mM DMPO + 1 mM H2O2 + 0.8 mg/ml MWCNT. All ESR spectra were obtained 
using the following settings: centre field = 3480 G, sweep width = 100 G, microwave 
frequency = 9.794 GHz, microwave power = 20.120 mW, receiver gain = 10,000 and signal 
channel time constant = 40.960 ms.
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TEM and field emission SEM images of MWCNT aerosol samples. The exposure chamber 
samples were collected by drawing aerosol from the chamber through 47-mm polycarbonate 
filters (Whatman, Clinton, PA) at a rate of 1 L/min. (Panel A) TEM images were 
photographed on a JEOL 1220 transmission electron microscope. (Panel B) Field emission 
SEM images were obtained with a Hitachi S4800.
Porter et al. Page 23














Transmission electron microscopy images of different stages in a MOUDI cascade impactor. 
The TEM images were used to determine count mode aerodynamic diameter of the 
MWCNT aerosol.
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A typical size distribution of the MWCNT aerosol in the exposure chamber (M = mass 
concentration and Dae = aerodynamic diameter). The distribution has a MMAD = 1.5 μm 
and a GSD of 1.67.
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MWCNT lung burden. (a) 2 days exposure = 16.6 ± 1.3 μg MWCNT, (b) 4 days exposure = 
32.5 ± 1.6 μg MWCNT, (c) 8 days exposure = 58.0 ± 3.9 μg MWCNT, and (d) 12 days 
exposure = 76.7 ± 3.0 μg MWCNT.
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Lung distribution of MWCNT. Mice were exposed by inhalation exposure to air or 
MWCNT (10 mg/m3) for 4 days and the lungs were collected at 1 day post-exposure. (Panel 
A) No MWCNT were observed in air-exposed controls. (Panel B) MWCNT were observed 
in the bronchioles and proximal alveolar region of MWCNT-exposed mice. (Panel C) 
Morphometric analyses of MWCNT distribution. Values are means ± SE (n = 8). (Panel D) 
MWCNT were observed at the pleural wall.
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Pulmonary inflammation and chemokine KC protein are induced by exposure to MWCNT. 
Mice were exposed by inhalation exposure to air (vehicle) or MWCNT (10 mg/m3) for 2, 4, 
8 or 12 days. WLL studies were conducted at 1 day post-exposure. (Panel A) Pulmonary 
inflammation was assessed by determining WLL PMN. (Panel B) The chemokine KC, 
which is a neutrophil chemoattractant, was determined in first WLL fluid. Values are means 
± SE (n = 7–9). Bars with different letters are significantly different (p < 0.05). An asterisk 
indicates air-exposed controls were significantly lower (p < 0.05) in comparison to the 
corresponding MWCNT-exposed group.
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WLL fluid LDH activities and albumin concentration. Mice were exposed by inhalation 
exposure to air (vehicle) or MWCNT (10 mg/m3) for 2, 4, 8 or 12 days. WLL studies were 
conducted at 1 day post-exposure. (Panel A) WLL fluid LDH activities. (Panel B) WLL 
fluid albumin concentrations. Values are means ± SE (n = 7–9). Bars with different letters 
are significantly different (p < 0.05). Asterisk indicates air-exposed controls were 
significantly lower (p < 0.05) in comparison to the corresponding MWCNT-exposed group.
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Histopathologic changes in the lung of MWCNT-exposed mice. (Panel A) Mice exposed to 
air had normal histology at the bronchioloalveolar junction. Bar = 20 μm. (Panel B) Mice 
exposed to MWCNT had hypertrophy and hyperplasia of the bronchiolar epithelium (dashed 
arrows), macrophages containing phagocytised MWCNT within the bronchiolar lumen, and 
interstitial and alveolar inflammation (*) centered at the bronchioloalveolar junction. Bar = 
20 μm. (Panel C) Nuclear abnormalities in alveolar macrophages included loss of nuclear 
staining consistent with karyolysis (dashed arrow) and, in this section, something almost 
never seen in controls, an abnormal mitotic figure with an apparent association between 
MWCNT and chromatin (solid arrow). Bar = 10 μm. (Panel D) A partially polarised section 
of bronchiolar epithelium shows intraepithelial MWCNT (solid arrows). Bar = 10 μm. 
(Panel E) Alcian-blue/PAS stained sections of airway epithelium in the MWCNT-exposed 
mice revealed mucous metaplasia as demonstrated by magenta to purple cytoplasmic 
staining of mucosubstances. Bar = 20 μm. (Panel F) Fibrosis (arrows) was usually 
bronchiolocentric, in foci of inflammation. Excess collagen deposition was demonstrated by 
blue staining in Masson’s trichrome-stained sections. Bar = 20 μm. (Panel G) Vasculitis with 
mural MWCNT (solid arrows). A macrophage at the margins of the tunica adventitia 
contains incompletely phagocytised MWCNT (dashed arrow). Bar = 20 μm. (Panel H) 
Pleural penetration of MWCNT with phagocytosis of the pleural MWCNT. Bar = 10 μm.
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Augmented microscopic imaging of lung after 12 days of MWCNT exposure. (Panel A) A 
confocal photomicrograph of lamin-B immunofluorescence and ethidium homodimer-1 
staining of permeabilized cells localizes the alveolar duct region of the lung, while low-level 
transmitted light reveals occasional MWCNT deposited in the optical section. The MWCNT 
appear black due to blocking of transmitted light. Bar = 20 μm. (Panel B) A confocal 
photomicrograph of an optical section of a reflected light image from the macrophage in the 
square of Panel A to demonstrate MWCNT, while multitracking allows demonstration of the 
nuclear envelope by green lamin B1 staining and nucleic acid by red ethidium homodimer-1 
staining to localize the MWCNT that penetrates the nucleus. Bar = 2 μm. (Panel C) 
Enhanced-darkfield light microscopic image of a cytospin slide showing a macrophage with 
a long MWCNT penetrating the nucleus. Bar = 20 μm. (Panel D) Enhanced-darkfield light 
microscopic image showing pleural penetration by a MWCNT.
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Lymph node changes after MWCNT exposure. (Panel A) Tracheobronchial lymph nodes 
were within normal limits in air-exposed control mice. (Panel B) In MWCNT-exposed mice, 
lymph nodes were enlarged with hyperplasia principally localized to the deep paracortex (*). 
Bar = 500 μm.
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Lymph node changes after MWCNT exposure. (Panel A) High magnification image of cells 
in the expanded lymph node para-cortex from a MWCNT-exposed mouse with 
intractyoplasmic MWCNT and nuclear debris (arrow). Bar = 20 μm. (Panel B) Higher 
magnification partially polarized image of a macrophage containing nuclear debris and 
MWCNT. The partial polarisation facilitates demonstration of MWCNT but causes a 
slightly blurry appearance. A MWCNT appears to penetrate the nucleus and chromatin is 
clumped beneath the nuclear envelope. Bar = 10 μm.
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Comparison of pulmonary inflammation induced by exposure to MWCNT by aspiration 
exposure (10 μg/mouse) or inhalation exposure (10 mg/m3, 4 days, MWCNT lung burden = 
13.0 ± 0.6 μg/lung) at 1 day post-exposure. Vehicle-exposed groups for aspiration study and 
inhalation study were 0.75 ± 0.37 PMN (103 cells/mouse) and 0.30 ± 0.00 PMN (103 cells/
mouse), respectively. Values are means ± SE (n = 7–9).
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Table II
Summary of histopathology findings in the tracheobronchial lymph node.
Exposure duration (days) Exposure Total n Hyperplasia MWCNT translocation
4 Air 8 0 (n = 4) 0 (n = 4)
Not found (n = 4) Not found (n = 4)
MWCNT 8 0 (n = 4) 0 (n = 2)
2 (n = 2) 1 (n = 5)
3 (n = 1) Not found (n = 1)
Not found (n = 1)
8 Air 6 0 (n = 4) 0 (n = 4)
Not found (n = 2) Not found (n = 2)
MWCNT 6 2 (n = 1) 2 (n = 2)
3 (n = 1) Not found (n = 4)
Not found (n = 4)
12 Air 6 0 (n = 3) 0 (n = 3)
Not found (n = 3) Not found (n = 3)
MWCNT 6 3 (n = 5)* 3 (n = 5)*
Not found (n = 1) Not found (n = 1)
Values represent severity score (on a scale of 1 to 5) and inside parentheses the number of animals (n) with that score; A designation of not found is 
included because the ability to find a mouse tracheobronchial lymph node is influenced by the size of the lymph node;
*
Significant difference between control and MWCNT exposure group.
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